Jr. Software Engineer - Part-time Position jobs in United States
cer-icon
Apply on Employer Site
company-logo

mdxhealth · 7 hours ago

Jr. Software Engineer - Part-time Position

Mdxhealth is building a world class healthcare company, providing significant career development and financial opportunities. The Junior Software Engineer will contribute to the development of software solutions for both customer-facing products and internal systems, working closely with senior developers and engineers on various tasks including design discussions and implementation.

BiotechnologyHealth DiagnosticsMedical Device

Responsibilities

Contribute to the development of software solutions for both customer-facing products and internal systems
Have strong foundation in computer science principles, object-oriented programming, and database design to build, test, and maintain software applications, databases, and system integrations
Work closely with senior developers and engineers, participating in design discussions, implementation, testing, and ongoing support

Qualification

Object-oriented programmingSoftware developmentDatabase designScripting languagesSDLC

Required

4+ years' experience in software development, systems engineering, technical support
Experience implementing business applications using SDLC and supporting software-based solutions in production environments
Proficiency in at least one object-oriented programming language such as C++, Java, or equivalent, applying object-oriented principles to design, build, enhance, and maintain scalable applications
Hands-on experience with at least one scripting language (e.g., Python, JavaScript, or similar) for automation, data processing, system integration, or tooling support

Benefits

Company paid medical, dental, vision and life insurance coverage
401(k) with company match
Generous employee discounts
A casual, but driven work environment

Company

mdxhealth

twittertwittertwitter
company-logo
MDxHealth is a molecular diagnostics company that develops epigenetic tests for cancer assessment and personalized treatment of patients.

Funding

Current Stage
Public Company
Total Funding
$169.38M
Key Investors
Innovatus Capital PartnersMVM Life Science PartnersKreos Capital
2024-09-25Post Ipo Equity· $40M
2023-02-03Post Ipo Equity· $37M
2022-08-02Post Ipo Debt· $35M

Leadership Team

leader-logo
John A. Bellano
Chief Commercial Officer
linkedin
Company data provided by crunchbase